MARINEH VENTRESCA: Open Payments
NPI 1245950088 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 30 payments from 10 companies in 2025. Trend: 2023 $149 · 2024 $307 · 2025 $763
Food & beverage: $668Education: $95
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $161 |
| SHIELD THERAPEUTICS INC | 5 | $127 |
| Sage Therapeutics, LLC | 6 | $105 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Smith+Nephew, Inc. | 2 | $77 |
| Organon LLC | 2 | $68 |
| Hologic Sales and Service, LLC | 2 | $49 |
| Exeltis, USA Inc. | 2 | $43 |
| CooperSurgical, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
Products named: ACCRUFER, ZURZUVAE, MYFEMBREE, Pico 14, NEXPLANON, Veozah, THINPREP 2000 PROCESSOR, SLYND.
Industry payments across CA — which companies pay providers there.
